1. Home
  2. GOSS vs PWOD Comparison

GOSS vs PWOD Comparison

Compare GOSS & PWOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOSS
  • PWOD
  • Stock Information
  • Founded
  • GOSS 2015
  • PWOD 1934
  • Country
  • GOSS United States
  • PWOD United States
  • Employees
  • GOSS N/A
  • PWOD N/A
  • Industry
  • GOSS Biotechnology: Pharmaceutical Preparations
  • PWOD Major Banks
  • Sector
  • GOSS Health Care
  • PWOD Finance
  • Exchange
  • GOSS Nasdaq
  • PWOD Nasdaq
  • Market Cap
  • GOSS 212.9M
  • PWOD 179.7M
  • IPO Year
  • GOSS 2019
  • PWOD N/A
  • Fundamental
  • Price
  • GOSS $0.74
  • PWOD $29.87
  • Analyst Decision
  • GOSS Strong Buy
  • PWOD
  • Analyst Count
  • GOSS 5
  • PWOD 0
  • Target Price
  • GOSS $9.20
  • PWOD N/A
  • AVG Volume (30 Days)
  • GOSS 881.6K
  • PWOD 20.4K
  • Earning Date
  • GOSS 11-07-2024
  • PWOD 10-24-2024
  • Dividend Yield
  • GOSS N/A
  • PWOD 4.29%
  • EPS Growth
  • GOSS N/A
  • PWOD 19.44
  • EPS
  • GOSS N/A
  • PWOD 2.62
  • Revenue
  • GOSS $105,322,000.00
  • PWOD $68,054,000.00
  • Revenue This Year
  • GOSS N/A
  • PWOD N/A
  • Revenue Next Year
  • GOSS N/A
  • PWOD N/A
  • P/E Ratio
  • GOSS N/A
  • PWOD $11.40
  • Revenue Growth
  • GOSS N/A
  • PWOD 6.40
  • 52 Week Low
  • GOSS $0.50
  • PWOD $17.01
  • 52 Week High
  • GOSS $1.60
  • PWOD $30.19
  • Technical
  • Relative Strength Index (RSI)
  • GOSS 22.63
  • PWOD 69.30
  • Support Level
  • GOSS $0.78
  • PWOD $29.01
  • Resistance Level
  • GOSS $0.92
  • PWOD $28.30
  • Average True Range (ATR)
  • GOSS 0.05
  • PWOD 0.97
  • MACD
  • GOSS -0.01
  • PWOD 0.20
  • Stochastic Oscillator
  • GOSS 0.00
  • PWOD 86.56

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

About PWOD Penns Woods Bancorp Inc.

Penns Woods Bancorp Inc is the bank holding company for Jersey Shore State Bank and Luzerne Bank. The banks serve customers in North Central and North Eastern Pennsylvania through their retail banking, commercial banking, mortgage services and financial services divisions. The Banks are engaged in commercial and retail banking which includes the acceptance of time, savings, and demand deposits, the funding of commercial, consumer, and mortgage loans, and safe deposit services. Utilizing a branch office network, ATMs, Internet, and telephone banking delivery channels, the Banks deliver their products and services to the communities residing in.

Share on Social Networks: